Chase Dana M, Lin Chun Chieh, Craig Christine D, Fedewa Stacey A, Virgo Katherine S, Farley John H, Halpern Michael, Monk Bradley J
Division of Gynecologic Oncology, University of Arizona Cancer Center, and the Department of Obstetrics and Gynecology, Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, and the University of Arizona College of Public Health, Tucson, Arizona; and the Surveillance and Health Services Research Program, American Cancer Society, and the Department of Health Policy and Management, Emory University, Atlanta, Georgia.
Obstet Gynecol. 2015 Oct;126(4):792-802. doi: 10.1097/AOG.0000000000001033.
To assess whether there is an association of patient sociodemographic factors with stage at diagnosis, treatment, and overall survival in patients with vulvar cancer in the National Cancer Database.
This was a retrospective cohort study of patients with primary squamous vulvar carcinoma identified from the National Cancer Database (1998-2004). Multivariate logistic regression was conducted to examine risk factors associated with advanced-stage (stage III or IV) disease at diagnosis. Multivariable Cox regression models were performed to explore risk factors associated with 5-year all-cause mortality.
Of 11,153 patients, 42.3% (n=4,713) were diagnosed with stage I disease, 24.6% (n=2,745) stage II, 22.9% (n=2,556) stage III, and 10.2% (n=1,139) stage IV. Advanced stage was significantly associated with older age, nonprivate insurance, and treatment at a lower case volume center (P<.01). Of note, roughly 30% of patients with advanced-stage disease did not receive radiation therapy. Within the advanced stages, age 60 years or older and insurance type were associated with decreased survival (P<.01). In stage III disease, only black race and treatment at a community hospital were associated with a lower risk of death (P<.01).
Patient sociodemographic and clinical characteristics are significantly associated with vulvar cancer stage presentation, treatment, and survival. Unfortunately, within this disease, surgical approaches and adjuvant radiation do not appear consistent.
II.
在国家癌症数据库中评估外阴癌患者的社会人口统计学因素与诊断分期、治疗及总生存期之间是否存在关联。
这是一项对从国家癌症数据库(1998 - 2004年)中识别出的原发性鳞状外阴癌患者进行的回顾性队列研究。采用多变量逻辑回归分析来检查与诊断时晚期(III期或IV期)疾病相关的危险因素。运用多变量Cox回归模型来探索与5年全因死亡率相关的危险因素。
在11153例患者中,42.3%(n = 4713)被诊断为I期疾病,24.6%(n = 2745)为II期,22.9%(n = 2556)为III期,10.2%(n = 1139)为IV期。晚期与年龄较大、无私人保险以及在病例数较少的中心接受治疗显著相关(P <.01)。值得注意的是,大约30%的晚期疾病患者未接受放射治疗。在晚期患者中,60岁及以上年龄和保险类型与生存率降低相关(P <.01)。在III期疾病中,只有黑人种族和在社区医院接受治疗与较低的死亡风险相关(P <.01)。
患者的社会人口统计学和临床特征与外阴癌的分期表现、治疗及生存显著相关。遗憾的是,对于这种疾病,手术方法和辅助放疗似乎并不一致。
II级。